"Home self-administration of omalizumab." Journal of Dermatological Treatment, 29(2), p. 196
Disclosure statement
Simon Francis Thomsen is a speaker and investigator and has received consultancy fees and research support from Novartis.
Additional information
Funding
Simon Francis Thomsen is a speaker and investigator and has received consultancy fees and research support from Novartis.